Brokerages Set Ardent Health Partners, LLC (NYSE:ARDT) Target Price at $20.58

Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) have been given an average rating of "Buy" by the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $20.58.

ARDT has been the topic of a number of recent research reports. Morgan Stanley lowered their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Guggenheim initiated coverage on Ardent Health Partners in a research report on Wednesday, April 9th. They set a "buy" rating and a $16.00 target price for the company. Truist Financial decreased their price target on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Mizuho cut their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Finally, Stephens restated an "overweight" rating and issued a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday, April 1st.

Institutional Trading of Ardent Health Partners

Several institutional investors have recently modified their holdings of the business. BNP Paribas Financial Markets bought a new position in Ardent Health Partners during the 3rd quarter worth $42,000. State Street Corp bought a new position in shares of Ardent Health Partners during the third quarter worth about $1,977,000. Jane Street Group LLC acquired a new position in shares of Ardent Health Partners in the third quarter worth approximately $567,000. Barclays PLC bought a new stake in Ardent Health Partners in the third quarter valued at approximately $385,000. Finally, Geode Capital Management LLC bought a new stake in Ardent Health Partners in the third quarter valued at approximately $2,581,000.

Ardent Health Partners Trading Up 2.4 %

Shares of NYSE:ARDT traded up $0.29 on Friday, hitting $12.59. The company had a trading volume of 52,766 shares, compared to its average volume of 445,226. The stock has a 50 day moving average price of $13.44 and a 200 day moving average price of $15.44. Ardent Health Partners has a 1-year low of $11.31 and a 1-year high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. On average, sell-side analysts expect that Ardent Health Partners will post 1.23 earnings per share for the current fiscal year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.